Assura PLC
LSE:AGR
P/S
Price to Sales
Price to Sales (P/S) ratio is a valuation multiple that compares a company’s market capitalization to its revenues. It is an indicator of the value that financial markets have placed on each dollar of a company’s sales.
Market Cap | P/S | ||||
---|---|---|---|---|---|
UK |
Assura PLC
LSE:AGR
|
1.3B GBP | 8.2 | ||
US |
Welltower Inc
NYSE:WELL
|
56.1B USD | 8.5 | ||
US |
Ventas Inc
NYSE:VTR
|
19.3B USD | 4.2 | ||
US |
Physicians Realty Trust
NYSE:DOC
|
13.8B USD | 6.3 | ||
US |
Healthpeak Properties Inc
NYSE:PEAK
|
9.7B USD | 4.5 | ||
US |
Omega Healthcare Investors Inc
NYSE:OHI
|
7.6B USD | 7.8 | ||
US |
Healthcare Trust Of America Inc
NYSE:HTA
|
6.1B USD | 7.9 | ||
US |
Healthcare Realty Trust Inc
NYSE:HR
|
6.1B USD | 4.5 | ||
US |
CareTrust REIT Inc
NASDAQ:CTRE
|
3.5B USD | 15.3 | ||
US |
Sabra Health Care REIT Inc
NASDAQ:SBRA
|
3.4B USD | 5.1 | ||
US |
Medical Properties Trust Inc
NYSE:MPW
|
3.3B USD | 4.2 |
P/S Forward Multiples
Forward P/S multiple is a version of the P/S ratio that uses forecasted revenue for the P/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.